These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10828876)

  • 1. Factor V Leiden mutation as a predisposing factor for veno-occlusive disease following BMT.
    Ertem M; Akar N
    Bone Marrow Transplant; 2000 May; 25(10):1110-1. PubMed ID: 10828876
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic veno-occlusive disease following peripheral blood stem cell or bone marrow transplantation.
    Salat C; Holler E; Hiller E; Pihusch R; Kolb HJ
    Haematologica; 1999 Jun; 84 Suppl EHA-4():40-3. PubMed ID: 10907464
    [No Abstract]   [Full Text] [Related]  

  • 3. The prothrombin gene variant G20210A but not factor V leiden may be associated with veno-occlusive disease following BMT.
    Duggan C; Schmidt M; Lawler M; White B; Cusack S; McCann S; Smith O
    Bone Marrow Transplant; 1999 Sep; 24(6):693-4. PubMed ID: 10490739
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk-adjusted monitoring of veno-occlusive disease following Bayesian individualization of busulfan dosage for bone marrow transplantation in paediatrics.
    Brice K; Valerie B; Claire G; Valerie M; Yves B; Gilles A; Nathalie B
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):135-43. PubMed ID: 17952879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study.
    Lee JH; Lee KH; Kim S; Lee JS; Kim WK; Park CJ; Chi HS; Kim SH
    Bone Marrow Transplant; 1998 Nov; 22(9):883-8. PubMed ID: 9827816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in protein C, factor VII and endothelial markers after autologous bone marrow transplantation: possible implications in the pathogenesis of veno-occlusive disease.
    Bazarbachi A; Scrobohaci ML; Gisselbrecht C; Marolleau JP; Mansi A; Brice P; Gorra P; Drouet L
    Nouv Rev Fr Hematol (1978); 1993 Apr; 35(2):135-40. PubMed ID: 8332449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation for severe aplastic anemia.
    Lee JH; Lee KH; Choi SJ; Min YJ; Kim JG; Kim S; Lee JS; Kim SH; Park CJ; Chi HS; Kim WK
    Bone Marrow Transplant; 2000 Sep; 26(6):657-62. PubMed ID: 11041568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor V Leiden: an overview.
    Shaw DM
    Clin Lab Sci; 2006; 19(4):218-21. PubMed ID: 17181126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation as definitive treatment for a factor V Leiden mutation.
    Dunn SP; Tsai A; Griffin G; Toth S; Casas-Melley AT; Falkenstein KP; Marando CA; Krueger LJ
    J Pediatr; 2005 Mar; 146(3):418-22. PubMed ID: 15756233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
    Wåhlander K; Larson G; Lindahl TL; Andersson C; Frison L; Gustafsson D; Bylock A; Eriksson BI
    Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic veno-occlusive disease following bone marrow transplantation.
    Grandt NC
    Oncol Nurs Forum; 1989; 16(6):813-7. PubMed ID: 2687804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenic infarction from factor V Leiden mutation.
    Lopez F; Mega A; Schiffman F; Sweeney J
    Am J Hematol; 1999 Sep; 62(1):62-3. PubMed ID: 10467437
    [No Abstract]   [Full Text] [Related]  

  • 13. Early postoperative obstructive prosthetic mitral valve thrombosis in a patient double heterozygous for factor V Leiden and prothrombin G20210A mutation.
    De Paulis S; Rossi E; Zamparelli R; Scapigliati A; Corrado M; De Stefano V
    Thromb Haemost; 2008 Feb; 99(2):441-2. PubMed ID: 18278197
    [No Abstract]   [Full Text] [Related]  

  • 14. A Thai patient with the mutation of Arg306 of FV gene identical to the Hong Kong but not to the Cambridge type.
    Hiyoshi M; Hashimoto S; Tagawa S; Arnutti P; Prayoonwiwat W; Tatsumi N
    Thromb Haemost; 1999 Nov; 82(5):1553-4. PubMed ID: 10595653
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis C virus as a risk factor for the development of veno-occlusive disease of the liver.
    Ljungman P; Hägglund H; Lönnqvist B; Sönnerborg A; Ringdén O
    Blood; 1994 Aug; 84(4):1349-50. PubMed ID: 8049452
    [No Abstract]   [Full Text] [Related]  

  • 16. Discrepancy between phenotype and genotype on screening for factor V Leiden after transplantation.
    Parker J; Pagliuca A; Kitiyakara T; Whitehead M; Heaton N; O'Grady J; Arya R
    Blood; 2001 Apr; 97(8):2525-6. PubMed ID: 11307773
    [No Abstract]   [Full Text] [Related]  

  • 17. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
    Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
    Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
    El-Karaksy H; El-Koofy N; El-Hawary M; Mostafa A; Aziz M; El-Shabrawi M; Mohsen NA; Kotb M; El-Raziky M; El-Sonoon MA; A-Kader H
    Ann Hematol; 2004 Nov; 83(11):712-5. PubMed ID: 15309526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
    Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
    Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.